Potential ovarian cancer treatment proves effective in pre-clinical studies
Promising treatment for ovarian cancer reaches final stages of clinical trials
Advances in ovarian cancer, from biology to treatment | Nature Cancer
Breast and Ovarian Cancer Clinical Trials
BEVACIZUMAB IN OVARIAN CANCER -Clinical Trials Ongoing | Download Table
Ovarian cancer clinical trials involving miRs. | Download Table
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome - European Journal of Cancer
Recurrent Epithelial Ovarian Cancer: An Update on Treatment
Clinical Trial – Treatment for Ovarian Cancer.
Ovarian cancer treatment: late-stage pipeline partnerships
Phase II Clinical Trials May Be on the Way for Ovarian Cancer - NFCR
BEVACIZUMAB IN OVARIAN CANCER: Phase III Trial -Clinical Trials Ongoing | Download Table
Mucinous Ovarian Carcinoma | NEJM
JCI Insight - Phase II clinical trial of metformin as a cancer stem cell–targeting agent in ovarian cancer
Clinical trials results for PARP Inhibitors in ovarian cancer. | Download Table
Ovarian Cancer | Symptoms, Diagnosis & Treatment | MD Anderson Cancer Center
Fact Sheet Ovarian Cancer Clinical Trial - BioCanRx
Prediction of the treatment response in ovarian cancer: a ctDNA approach | Journal of Ovarian Research | Full Text
Current treatment strategy in ovarian cancer is illustrated. HGSOC,... | Download Scientific Diagram
Ovarian cancer clinical trial workflow. Fig 1 depicts an overview on... | Download Scientific Diagram
Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgery -
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline - Gynecologic Oncology
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial - The Lancet
Epithelial ovarian cancer - The Lancet
Chemotherapy of ovarian cancer (Chapter 26) - Altchek's Diagnosis and Management of Ovarian Disorders
